These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3052672)

  • 21. Tumor regression mediated by Mycobacterium bovis (strain BCG).
    Zbar B
    Natl Cancer Inst Monogr; 1972 Dec; 35():341-4. PubMed ID: 4572832
    [No Abstract]   [Full Text] [Related]  

  • 22. The characterization and immunoreactivity of a 70 kD protein common to Mycobacterium leprae and Mycobacterium bovis (BCG).
    Britton WJ; Garsia RJ; Hellqvist L; Watson JD; Basten A
    Lepr Rev; 1986 Dec; 57 Suppl 2():67-75. PubMed ID: 3553805
    [No Abstract]   [Full Text] [Related]  

  • 23. [Model of allergy of the immediate type to BCG and analysis of allergic reactivity in BCG vaccination in experiments].
    Beklemishev ND; Sukhodoeva GS; Bul'vakhter IaL
    Probl Tuberk; 1975; (12):53-8. PubMed ID: 768978
    [No Abstract]   [Full Text] [Related]  

  • 24. [Action of hydrocortisone on the cytotoxic reactions in delayed hypersensitivity to microbial antigens].
    Bazanova EA; Smirnova MN; Liampert IM
    Biull Eksp Biol Med; 1985 Jun; 99(6):723-5. PubMed ID: 2410059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of the line-10 guinea pig hepatocarcinoma by antigens related to both Mycobacterium bovis (BCG) and the tumor.
    Minden P; Mathews HL; Kelleher PJ
    J Immunol; 1980 Dec; 125(6):2685-9. PubMed ID: 7000904
    [No Abstract]   [Full Text] [Related]  

  • 26. Strain difference in delayed-type hypersensitivity to BCG in mice: role of splenic adherent cells in the primary immune response.
    Nakamura RM; Tanaka H; Tokunaga T
    Immunology; 1982 Dec; 47(4):729-31. PubMed ID: 6216204
    [No Abstract]   [Full Text] [Related]  

  • 27. [Isolation of species-specific Mycobacterium bovis antigen and testing of its cutaneous tuberculin activity].
    Liashchenko KP; Bobrovnik SA; Komissarenko SV
    Probl Tuberk; 1991; (8):12-4. PubMed ID: 1722040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunotherapy of guinea pig cancer with BCG.
    Zbar B
    Johns Hopkins Med J Suppl; 1974; 3():121-30. PubMed ID: 4608693
    [No Abstract]   [Full Text] [Related]  

  • 29. [Study of unheated filtrates of Mycobacterium cultures. Immunological characteristics of Mycobacterium avium cultures].
    Michalska K; Pelczarska B
    Pneumonol Pol; 1982 Oct; 50(10):489-96. PubMed ID: 6189101
    [No Abstract]   [Full Text] [Related]  

  • 30. Studies on diagnostic potential of secretory antigens of Mycobacterium bovis.
    Trivedi S; Das SK; Kumar R; Chandra R
    Indian J Exp Biol; 2006 Jan; 44(1):14-8. PubMed ID: 16430085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation of a BCG substrain specific elicitin.
    Niculescu D; Stavri D
    Arch Roum Pathol Exp Microbiol; 1981; 40(2):117-22. PubMed ID: 7030273
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparison of lymphocyte transformation, inhibition of macrophage migration and skin tests using dialyzable and nondialyzable tuberculin fractions from Mycobacterium bovis (BCG).
    Chaparas SD; Thor DE; Hedrick SR
    J Immunol; 1971 Jul; 107(1):149-53. PubMed ID: 4933403
    [No Abstract]   [Full Text] [Related]  

  • 33. Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis.
    Sun R; Skeiky YA; Izzo A; Dheenadhayalan V; Imam Z; Penn E; Stagliano K; Haddock S; Mueller S; Fulkerson J; Scanga C; Grover A; Derrick SC; Morris S; Hone DM; Horwitz MA; Kaufmann SH; Sadoff JC
    Vaccine; 2009 Jul; 27(33):4412-23. PubMed ID: 19500523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The formation of delayed hypersensitivity to mycobacterial antigens].
    Liashchenko KP; Bobrovnik SA; Komissarenko SV
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Apr; (4):66-8. PubMed ID: 1882613
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of macrophage migration by a skin-reactive polysaccharide from BCG culture filtrates.
    Godfrey HP; Baer H; Chaparas SD
    J Immunol; 1969 Jun; 102(6):1466-73. PubMed ID: 4891552
    [No Abstract]   [Full Text] [Related]  

  • 36. Antigens of PPD, old tuberculin, and autoclaved Mycobacterium bovis BCG studied by crossed immunoelectrophoresis.
    Harboe M
    Am Rev Respir Dis; 1981 Jul; 124(1):80-7. PubMed ID: 7020505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The antigens of Mycobacterium bovis, strain BCG, studied by crossed immunoelectrophoresis: a reference system.
    Closs O; Harboe M; Axelsen NH; Bunch-Christensen K; Magnusson M
    Scand J Immunol; 1980; 12(3):249-63. PubMed ID: 7008186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathogenesis of pulmonary Mycobacterium bovis infection: basic principles established by the rabbit model.
    Dannenberg AM
    Tuberculosis (Edinb); 2001; 81(1-2):87-96. PubMed ID: 11463228
    [No Abstract]   [Full Text] [Related]  

  • 39. Enzymatic and antigenic analyses of strains of Mycobacterium bovis, M. bovis BCG, and M. tuberculosis.
    Ohman R; Ridell M
    Curr Microbiol; 1995 Mar; 30(3):161-5. PubMed ID: 7765849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immunologic methods of detection of peroxidase in homogenates of BCG substrains. I. Description and evaluation of methods of immunological detection of peroxidase].
    Rzucidlo L; Lipińska R
    Gruzlica; 1974 Dec; 42(12):1171-6. PubMed ID: 4215702
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.